Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 2 of 8 | Showing Results 6 - 10 of 40

A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy

Key Inclusion Criteria:-Histologically confirmed diagnosis of supratentorial GBM (Grade 4 astrocytoma)-Radiographic evidence of first recurrence or...

Ricky Chen, M.D.
  • Providence St. Vincent Medical Center

A Multicenter, Open-Label, Randomized Study of NovoTTF-200A Alone and Combined with Temozolomide in Patients with Low-Grade Gliomas

Key Inclusion Criteria:-Histologically confirmed, measureable low-grade glioma including grade 2 astrocytoma, oligdendroglioma, or...

Ricky Chen, M.D.
  • Providence St. Vincent Medical Center

Standard Chemotherapy versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients with Recurrent Glioblastoma Multiforme (GBM)

The purpose of this clinical study is to confirm the utility of chemosensitivity tumor testing on cancer stem cells (ChemoID) as a predictor of...

Ricky Chen, M.D.
  • Providence St. Vincent Medical Center

A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic strocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy STELLAR Study

The purpose of this study is to compare the efficacy and safety of eflornithine in combination with lomustine, compared to lomustine taken alone,...

Ricky Chen, M.D.

METIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)

The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC...

Ricky Chen, M.D.
  • Providence St. Vincent Medical Center
Viewing Page 2 of 8 | Showing Results 6 - 10 of 40